Background: Resting heart rate (which ranges from 60 to 80 bpm) is one of the simplest cardiovascular parameters, and has been considered as a predictor of cardiovascular and all-cause mortality.
Introduction
Intrinsic heart rate (HR), in the absence of any neurohumoral influence, is approximately 100 to 120 bpm. In the healthy individual, heart rate at rest reflects a balance between the tonically active sympathetic and parasympathetic systems, with a predominance of the latter. Such predominance results in a resting heart rate (RHR) that is lower than the intrinsic heart rate, one of the simplest cardiovascular parameters that usually ranges from 60 to 80 bpm 1 . Resting HR, or baseline HR, refers to the number of heartbeats per minute at rest 2 
.
Since 1980, it is known that resting heart rate is a prognostic factor for coronary artery disease (CAD) and that it is associated with cardiovascular 3 and all-cause 4 mortality.
Several past long-term follow-up studies have demonstrated the impact of elevated resting HR in the general population 5 , elderly subjects 6 , and hypertensive 7 as well as acute myocardial infarction pacients 6 , on both cardiovascular 8, 9 and all-cause 8, 10 . This finding has been confirmed by more recent studies. 9, 11, 12 . In multivariate analyses, many studies have found that by the U.S Centers for Disease Control (CDC), a sophisticated linkage mechanism, was used to mach the names from the database of the Exercise Testing Laboratory with those of the Death Registry. Matching was done by gender and the same year at which the exercise test had been performed. After data analysis, a total of 7,055 patients were selected: 1,645 for the case group (deceased) and 5,410 for the control group (the number of patients was greater in this group to minimize any potential bias resulting from deaths away from home).
The outcome measures selected were cardiovascular and all-cause mortality. Death was considered as due to cardiovascular disease if the death certificate listed acute myocardial infarction (AMI), cardiorespiratory arrest, angina pectoris, ischemic heart disease, cardiogenic shock, sudden death, congestive heart failure, arrhythmias, or other causes of death included in chapter IX of the International Classification of Diseases, 10th Revision (ICD-10) 16 . Before beginning the test, a seated resting heart rate was measured with a heart rate monitor and blood pressure (BP) was taken manually. The Bruce protocol 17 was used for most patients, and the indication for the test (about 98%) was based on the diagnosis. 
Results
A total of 7,055 patients were evaluated, 1,645 (23.3%) of whom were in the case group (deceased) and 5,410 (76.7%) in the control group (alive). The mean age of the study population was 55.43 ± 10.48 years, and 61.3% of the patients were male. The follow-up period was 12 years. Cardiovascular mortality rate was 9.5% (674 patients).
The distribution of the remaining variables between groups is shown in Table 1 . Mean resting HR of the case group (deceased), for both cardiovascular and all-cause death, was similar (83.18 ± 15.50 and 83.19 ± 15.50), but when it was compared with the control group (72.13 ± 12.64), there was a significant difference (p < 0.001). Smoking, diabetes, resting BP ≥ 140/90 mmHg and VO 2 max ≤ 28 ml/kg/min were more prevalent in the case group (CV and all-cause death) than in the control group (p < 0.001); cardiovascular drugs were more frequently used in the case group (CV death) (69%) than in the control group (57.5%), p < 0.001. Hypercholesterolemia and BMI ≥ 25 kg/m 2 were equally distributed among groups (p > 0.005).
Regarding age distribution, Table 2 shows that approximately 30% of the patients who died were in the 51 to 60 and 61 to 70 age groups; 6.4% (CV death) and 6.9% (all-cause death) were in the 25 to 40 age group; and 16.8% (CV death) and 15.3% (all-cause death) were in the 71 to 88 age group, greater than in the control group (3.5%). The age difference between groups was statistically significant (p < 0.001). Figure 1 depicts the ROC curves for the case group, both for CV and all-cause death, which were similar to one another; minimal resting HR was 41 bpm, and maximum resting HR was 134 bpm. The ROC curve analysis showed the optimal sensitivity (Se) and specificity (Sp) of the cut-off value of resting heart rate for all-cause death (sensitivity of 0.618 and 1 and specificity of 0. 315) and CV death (sensitivity of 0.614 and 1 and specificity of 0.315), resulting in 61% and 68%, respectively. The cut-off value for mortality, therefore, was RHR ≥ 78 bpm. Tables 3 and 4 show the correlation between the cut-off value for mortality and the significant variables of the study. Table 6 shows the logistic regression analysis for all-cause mortality. Male gender (OR 1.27, CI 1.11-1.45), smoking 
RHR -resting heart rate; F -female M -male VO 2 max -functional capacity. BP -blood pressure: CV -cardiovascular; OR -odds ratio; CI -confidence interval.

Discussion
In our study, elevated RHR was found to be associated with mortality, as reported by other authors 9, 14, 19, 20 .
In earlier studies, such as the National Health and Nutrition Examination Survey (NHANES), Spandau Health Test (SHT), and The Three Chicago Epidemiologic Studies, heart rate was associated with cardiovascular and noncardiovascular mortality 21 .
Other studies have confirmed these data, such as the CORDIS Trial and MATISS: Kristal-Boneh et al 11 , in the CORDIS trial, found that elevated RHR was strongly associated with both all-cause (RR 2.23, CI 1.4-3.6; RHR > 90 bpm) and cardiovascular mortality, even after controlling for many known risk factors. Seccareccia et al 13 , in the MATISS study, found that in a low-risk Italian population heart rate increment was associated with a RR increase of 1.52 (CI 1.29-1.78) for all-cause mortality and 1.63 (CI: 1.26-2.10) for cardiovascular mortality.
It is known that individuals with elevated resting heart rate have less HR variability (reflecting an imbalance in the autonomic nervous system), which predisposes to arrhythmias, heart failure, atherosclerosis and increased risk of death 22 . In . Cardiovascular risk factors are known to be associated with increased HR, therefore the effects of elevated HR in said age groups are even more deleterious 30, 31 .
Evaluated separately, RHR ≥ 78 bpm was found to have an impact on cardiovascular and all-cause mortality. In our study, the patients who died were more than three times as likely to have increased RHR than those who did not (OR 3.56 and 3.62, respectively). This finding supports the association of increased RHR with mortality. The deleterious effects of elevated HR have already been demonstrated in the Framingham study 21 . In this study, in a cohort of 5,070 subjects free of cardiovascular diseases at baseline, cardiovascular mortality increased progressively with resting heart rate.
The large number of patients included in our study makes it possible to confirm the hypothesis that the association of elevated RHR with mortality is not accidental.
Concluding, our findings suggest a relationship between RHR and mortality, from a cut-off value of RHR ≥ 78 bpm, found both in CV and all-case deaths, with greater risk in the 71 to 88 age group. In our study, RHR ≥ 78 bpm, even after adjustment for gender, diabetes, smoking, use of cardiovascular drugs, resting BP ≥ 140/90 mmHg, and VO 2 max ≤ 28 ml/kg/min, was found to be an independent predictor of cardiovascular and all-cause mortality.
Study limitations
Possible limitations to our results include the following: the origin, not described, of all patients undergoing exercise test (some may have come from the ER and have increased RHR); the method used to consider patients as alive in the study (i. e., the fact that they were not included in the death records of the Health Department); the reliability of the information abstracted from the Death Certificates; and the fact that the Kappa test was the only statistical method used to validate the study variables.
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this study, hypercholesterolemia and BMI ≥ 25 kg/m 2 were equally distributed between the case and control groups. Although no variable alone was significant, the association with other risk factors, such as systemic hypertension, cigarette smoking, and diabetes may increase mortality rates 23 .
All the remaining variables were associated with resting HR ≥ 78 bpm, as evidenced by several previous studies demonstrating that smoking, hypertension, diabetes, and sedentary lifestyle are associated with increased HR and mortality risk 7, 24, 25 . Only in the case group (CV death) was resting BP ≥ 140/90 mmHg significant, and the patients who died were 1.20 times more likely to have increased blood pressure. The impact of elevated heart rate on hypertensive as well as diabetic patients, increasing by three-to-four-fold the risk of cardiovascular events and twice the risk of dying from such an event, compared to the general population, is already well documented in the literature 4, 26, 27 . The adrenergic hyperactivity involved in these risk factors and the imbalance between the sympathetic and parasympathetic activities explain these findings 2 . Table 3 shows that patients with RHR ≥ 78 bpm tended to be women (42.8%), although cardiovascular death (65.9%) and all-cause death (64.3%) were more prevalent in men. Even though RHR was higher in women, the association with the development of hypertension, atherosclerosis, and CV morbidity and mortality is lower or absent in this group 28 . It is possible that women, especially premenopausal women, are protected from the deleterious effects of elevated HR due to an estrogen-associated increase in their serum HDLcholesterol levels 29 . As shown in Table 4 , patients who died
